Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 4036 AL 4050

Fatigue in Parkinson's disease

Herlofson K, Kluger BM.

J Neurol Sci. 2017 Mar 15;374:38-41. doi: 10.1016/j.jns.2016.12.061. Epub 2016 Dec 29.

Pathology of behavior in PD: What is known and what is not?

Ehgoetz Martens KA, Lewis SJ.

J Neurol Sci. 2017 Mar 15;374:9-16. doi: 10.1016/j.jns.2016.12.062. Epub 2016 Dec 29.

Application of the DREADD technique in biomedical brain research

Dobrzanski G, Kossut M.

Pharmacol Rep. 2017 Apr;69(2):213-221. doi: 10.1016/j.pharep.2016.10.015. Epub 2016 Oct 29.

Non-Naturally Occurring Small Molecule Microtubule-Stabilizing Agents: A Potential Tactic for CNS-Directed Therapies

Ballatore C, Brunden KR, Trojanowski JQ, Lee VM, Smith AB 3rd.

ACS Chem Neurosci. 2017 Jan 18;8(1):5-7. doi: 10.1021/acschemneuro.6b00384. Epub 2016 Nov 29.

The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders

Johnson MB, Young AD, Marriott I.

Front Cell Neurosci. 2017 Jan 4;10:296. doi: 10.3389/fncel.2016.00296. eCollection 2016.

Untangling Basal Ganglia Network Dynamics and Function: Role of Dopamine Depletion and Inhibition Investigated in a Spiking Network Model

Lindahl M, Hellgren Kotaleski J.

eNeuro. 2017 Jan 12;3(6):ENEURO.0156-16.2016. doi: 10.1523/ENEURO.0156-16.2016. eCollection 2016 Nov-Dec.

Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations

Maloney EM, Djamshidian A, O'Sullivan SS.

J Neurol Sci. 2017 Mar 15;374:47-52. doi: 10.1016/j.jns.2016.12.058. Epub 2016 Dec 28.

Long term risk of Wolff-Parkinson-White pattern and syndrome

Kim SS, Knight BP.

Trends Cardiovasc Med. 2017 May;27(4):260-268. doi: 10.1016/j.tcm.2016.12.001. Epub 2016 Dec 5.

Structural Characteristics of α-Synuclein Oligomers

Cremades N, Chen SW, Dobson CM.

Int Rev Cell Mol Biol. 2017;329:79-143. doi: 10.1016/bs.ircmb.2016.08.010. Epub 2016 Oct 31.

Perspective on the Road toward Gene Therapy for Parkinson's Disease

Blits B, Petry H.

Front Neuroanat. 2017 Jan 9;10:128. doi: 10.3389/fnana.2016.00128. eCollection 2016.

Assessing Visuospatial Skills in Parkinson's: Comparison of Neuropsychological Assessment Battery Visual Discrimination to the Judgment of Line Orientation

Renfroe JB, Turner TH, Hinson VK.

Arch Clin Neuropsychol. 2017 Feb;32(1):123-127. doi: 10.1093/arclin/acw102. Epub 2016 Nov 23.

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

Tetrud J, Nausieda P, Kreitzman D, Liang GS, Nieves A, Duker AP, Hauser RA, Farbman ES, Ellenbogen A, Hsu A, Kell S, Khanna S, Rubens R, Gupta S.

J Neurol Sci. 2017 Feb 15;373:116-123. doi: 10.1016/j.jns.2016.11.047. Epub 2016 Nov 23.

Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease

Balestrino R, Martinez-Martin P.

J Neurol Sci. 2017 Feb 15;373:173-178. doi: 10.1016/j.jns.2016.12.060. Epub 2016 Dec 28.

Parkinsonism related to Percheron artery infarct

Bejr-Kasem Marco H, Lorenzo-Bosquet C, Alvarez-Sabin J, Hernandez-Vara J.

J Neurol Sci. 2017 Feb 15;373:21-22. doi: 10.1016/j.jns.2016.12.011. Epub 2016 Dec 12.

Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects

Santos García D, Suárez Castro E, Expósito I, de Deus T, Tuñas C, Aneiros A, López Fernández M, Núñez Arias D, Bermúdez Torres M.

J Neurol Sci. 2017 Feb 15;373:210-215. doi: 10.1016/j.jns.2016.12.046. Epub 2016 Dec 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias